Live Breaking News & Updates on Prnewswire Nouscom

Stay updated with breaking news from Prnewswire nouscom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer

BASEL, Switzerland, Jan. 5, 2023 /PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced that it has entered ....

United States , Eleanor Perkin , Prnewswire Nouscom , Marwang Fakih , Richard Davis , Sylvie Berrebi , Bristol Myers Squibb , Marina Udier , Merck Co Inc , Merck Sharp Dohme , Janssen Research Development , Microsatellite Instable High , Metastatic Colorectal Cancer , Chief Executive Officer , Merck Sharp , Professor Marwan , Based Vaccine Promotes Neoantigen Specific , Science Translational Medicine , Great Ape Adenoviral , Modified Vaccinia Ankara , Lynch Syndrome Carriers , Myeloproliferative Neoplasms , Janssen Research ,

Nouscom Announces First Patient Dosed in Phase 2 Randomized Trial with NOUS-209, an 'off-the shelf' Neoantigen Cancer Immunotherapy in dMMR/MSI-High Metastatic Colorectal Cancer

BASEL, Switzerland, Nov. 15, 2022 /PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced the first patient ....

United States , Eleanor Perkin , Prnewswire Nouscom , Rick Davis , Marwang Fakih , Sylvie Berrebi , Bristol Myers Squibb , Michaelj Overman , Marina Udier , Kostenloser Wertpapierhandel , University Of Texas Md Anderson Cancer Center , Department Of Gastrointestinal Medical Oncology , Janssen Research Development , Microsatellite Instable High , Principal Investigator , Gastrointestinal Medical Oncology , Cancer Center , Science Translational , Chief Executive Officer , Lynch Syndrome , Professor Marwan , Based Vaccine Promotes Neoantigen Specific , Science Translational Medicine , Great Ape Adenoviral , Modified Vaccinia Ankara , Lynch Syndrome Carriers ,

Nouscom's Personalized Neoantigen Cancer Immunotherapy NOUS-PEV Demonstrates Promising Safety, Immunogenicity and Anti-tumor Activity in Solid Tumors

/PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced interim data from. ....

Eleanor Perkin , Prnewswire Nouscom , Rick Davis , Oliver Bechter , Sylvie Berrebi , Bristol Myers Squibb , Sven Gogov , Society For Immunotherapy Of Cancer , Leuven Cancer Institute Belgium , Janssen Research Development , Annual Meeting , Principal Investigator , General Medical Oncology , Leuven Cancer Institute , Chief Medical Officer , Presentation Details , Novel Personalized Viral Based , Interim Results , First Subjects , Modified Vaccinia Ankara , Vaccine Encoded Neontigens Unrestricted Selection , Novel Selection Approach , Lynch Syndrome Carriers , Myeloproliferative Neoplasms , Janssen Research ,

Nouscom announces leading publication revealing an immune mechanism of action driving anti-tumor activity of adenovirus vectored vaccines and anti-PD1 immunotherapy

/PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vectored immunotherapies, today announces the. ....

United States , Eleanor Perkin , Rick Davis , Prnewswire Nouscom , Sylvie Berrebi , Elisa Scarselli , American Association For Cancer Research , American Society Clinical Oncology , Candiolo Cancer Institute , Head Of The Armenise Harvard Laboratory Immunoregulation , Italian Institute For Genomic Research , Armenise Harvard Laboratory Of Immunoregulation , Science Translational Medicine , Armenise Harvard Laboratory , Luigia Pace , American Association , Cancer Research , Chief Scientific Officer , Italian Institute , Genomic Research , Based Vaccine Promotes Neoantigen Specific , Science Translational ,

Nouscom Announces Positive Full Phase 1 Data of NOUS-209, an 'off-the-shelf' Neoantigen Cancer Immunotherapy for the Treatment of dMMR/MSI-H Solid Tumors, at ASCO 2022

/PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vectored immunotherapies, today announced. ....

United States , Eleanor Perkin , Prnewswire Nouscom , Rick Davis , Marwang Fakih , Sylvie Berrebi , Marina Udier , American Association For Cancer Research , American Society Of Clinical Oncology , Clinical Oncology , Annual Meeting , Microsatellite Instable High , American Association , Cancer Research , Medical Oncology Specialist , Duarte California , Chief Executive Officer , Presentation Details , Microsatellite Instability , Professor Marwan , Great Ape Adenoviral , Modified Vaccinia Ankara ,